Redefining Brain Health
About Vitalesis
Vitalesis is a pioneering biotech company revolutionizing the landscape of Alzheimer's disease and related disorders through innovative diagnostic and therapeutic solutions. Transforming early detection, monitoring, and treatment of Alzheimer's disease globally.
Saudi Arabia
Australia
Global innovation, local impact
Our Mission:
To transform Alzheimer's disease management through early detection, accurate monitoring, and innovative treatment approaches, improving patient outcomes and quality of life globally.
Our Vision:
Empowering healthcare with solutions designed to save lives through groundbreaking technologies and a patient-first approach.
Our Innovative Solutions
01
Integrated Diagnostic Ecosystem
-
Combines digital, biological, and AI tools for seamless patient management.
02
Advanced Biomarker Detection
-
Blood-based diagnostics enabling detection 10-15 years before clinical onset.
-
Tracks immune genome changes for disease progression insights.
04
Data Intelligence Layer
-
Big data analytics for personalized care.
-
Global health trend analysis with secure data management.
03
AI-Powered Health Management
-
Personalized health coaching and cognitive tracking.
-
Predictive insights into disease progression and treatment efficacy.
Founders
Sultan Alhayyani
An Associate Professor of Biochemistry at King Abdulaziz University, Dr. Alhayyani holds a Master’s from Harvard University and brings expertise from GreenLight BioSciences. Recognized globally for his achievements, he leads Vitalisys with a vision for groundbreaking biotech innovation.
Mourad Tayebi
An Associate Professor at Western Sydney University with 20+ years in Alzheimer's research, specializing in neuroscience, neuroimmunology, and biologics for protein misfolding diseases. Founder of two startups advancing dementia treatment and detection.
Join us in transforming Alzheimer's care and creating a healthier future through innovation and impact.
Fill out the form below and let Viento's experts help